Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.

Wang X, Cheng W, Liu C, Li J.

Oncotarget. 2016 Jun 28;7(26):40792-40799. doi: 10.18632/oncotarget.8215. Review.

2.

Radiation exposure, young age, and female gender are associated with high prevalence of RET/PTC1 and RET/PTC3 in papillary thyroid cancer: a meta-analysis.

Su X, Li Z, He C, Chen W, Fu X, Yang A.

Oncotarget. 2016 Mar 29;7(13):16716-30. doi: 10.18632/oncotarget.7574.

3.

BRAF(V600E) Mutation, RET/PTC1 and PAX8-PPAR Gamma Rearrangements in Follicular Epithelium Derived Thyroid Lesions - Institutional Experience and Literature Review.

Şahpaz A, Önal B, Yeşilyurt A, Han Ü, Delibaşı T.

Balkan Med J. 2015 Apr;32(2):156-66. doi: 10.5152/balkanmedj.2015.15101. Epub 2015 Apr 1.

4.

Genetics and epigenetics of sporadic thyroid cancer.

Vu-Phan D, Koenig RJ.

Mol Cell Endocrinol. 2014 Apr 5;386(1-2):55-66. doi: 10.1016/j.mce.2013.07.030. Epub 2013 Aug 8. Review.

5.

Papillary thyroid carcinoma: differential diagnosis and prognostic values of its different variants: review of the literature.

Gonzalez-Gonzalez R, Bologna-Molina R, Carreon-Burciaga RG, Gómezpalacio-Gastelum M, Molina-Frechero N, Salazar-Rodríguez S.

ISRN Oncol. 2011;2011:915925. doi: 10.5402/2011/915925. Epub 2011 Dec 6.

6.

Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival.

Morris LG, Shaha AR, Tuttle RM, Sikora AG, Ganly I.

Thyroid. 2010 Feb;20(2):153-8. doi: 10.1089/thy.2009.0352.

7.

Human thyroid tumours, the puzzling lessons from E7 and RET/PTC3 transgenic mice.

Jin L, Burniat A, Dumont JE, Miot F, Corvilain B, Franc B.

Br J Cancer. 2008 Dec 2;99(11):1874-83. doi: 10.1038/sj.bjc.6604740. Epub 2008 Nov 4. Erratum in: Br J Cancer. 2009 Mar 24;100(6):1013.

8.

Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness.

Williams ED, Abrosimov A, Bogdanova T, Demidchik EP, Ito M, LiVolsi V, Lushnikov E, Rosai J, Sidorov Y, Tronko MD, Tsyb AF, Vowler SL, Thomas GA.

Br J Cancer. 2004 Jun 1;90(11):2219-24.

9.

Genetic and biological subgroups of low-stage follicular thyroid cancer.

French CA, Alexander EK, Cibas ES, Nose V, Laguette J, Faquin W, Garber J, Moore F Jr, Fletcher JA, Larsen PR, Kroll TG.

Am J Pathol. 2003 Apr;162(4):1053-60.

10.

Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.

Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G.

Am J Pathol. 2002 Jun;160(6):2157-67.

11.

Molecular rearrangements and morphology in thyroid cancer.

Kroll TG.

Am J Pathol. 2002 Jun;160(6):1941-4. Review. No abstract available.

Supplemental Content

Support Center